AUSPEX Pharmaceuticals, Inc.

AUSPEX

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in opthalmology and for gastroenterological disorders;

AUSTEDO

Pharmaceutical preparations for the treatment of central nervous system diseases, namely, neurodegeneration, psychiatric conditions, pain, movement disorders;

AUSTEDO

The mark consists of a stack of three generally horizontal lines. The top line is light blue. The middle line is purple and is shorter than the top line. The bottom line is grey and is shorter than the middle line. The mark also includes, to the right of the stack, a purple and stylized version of the term Austedo.;Pharmaceutical preparations for the treatment of central nervous system diseases, namely, neurodegeneration, psychiatric conditions, pain, movement disorders;The color(s) Purple, light blue and gray is/are claimed as a feature of the mark.;